Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-01-02 @ 4:31 AM
Study NCT ID:
NCT03557359
Status:
COMPLETED
Last Update Posted:
2025-11-03
First Post:
2018-05-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab for Recurrent or Progressive IDH Mutant Gliomas
Sponsor:
Fabio Iwamoto, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-11
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-17
First Submit QC Date:
None
Study First Post Date:
2018-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-09
Results First Submit QC Date:
None
Results First Post Date:
2025-11-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-09
Last Update Post Date:
2025-11-03
Last Update Post Date Type:
ESTIMATED